Andere Sprachen Prestige Consumer Healthcare Inc.

Aktien

A0DN17

US74112D1019

PBH

Realtime-Estimate Cboe BZX Andere Börsenplätze 15:47:26 02.05.2024			% 5 Tage	% 1. Jan.
71,33 ^USD	+0,30 %		+1,92 %	+16,78 %

16.02.	Insider von Prestige Consumer Healthcare verkaufte Aktien im Wert von $1.766.665, laut einer aktuellen SEC Einreichung	MT
16.02.	Insider von Prestige Consumer Healthcare verkaufte Aktien im Wert von $2.051.874, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Prestige Consumer Healthcare : Clawback Policy	25.04.
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results	25.04.
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag	03.04.
Prestige Consumer Healthcare : Consumer Analyst Group of New York (CAGNY) 2024 Luncheon Presentation	07.03.
Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing	16.02.
Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing	16.02.
Prestige Consumer Healthcare Insider Sold Shares Worth $368,184, According to a Recent SEC Filing	12.02.
Prestige Consumer Healthcare's Fiscal Q3 Earnings, Revenue Increase; Raises 2024 Earnings Guidance; Shares Gain	08.02.
North American Morning Briefing : S&P 500 to Open -2-	08.02.
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 Revenue $282.7M, vs. Street Est of $280.4M	08.02.
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 EPS $1.06, vs. Street Est of $1.04	08.02.
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot	08.02.
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results	08.02.
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08.02.
Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Year of Fiscal 2024	08.02.
Prestige Consumer Healthcare Unit Recalls 2 Lots of Ting Antifungal Spray Liquid on High Levels of Benzene	02.02.
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02.02.
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02.02.
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10.01.
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Prestige Consumer Healthcare Inc.

Aktien

A0DN17

US74112D1019

PBH

Andere Sprachen

Filter